Portal de Periódicos da CAPES

A French cohort for assessing COVID-19 vaccine responses in specific populations

2021; Nature Portfolio; Volume: 27; Issue: 8 Linguagem: Inglês

10.1038/s41591-021-01435-1

1546-170X

Paul Loubet, Linda Wittkop, Éric Tartour, Béatrice Parfait, Benoı̂t Barrou, Jean‐Yves Blay, Maryvonne Hourmant, Marie Lachâtre, David Laplaud, Martine Laville, Bruno Laviolle, Jean‐Daniel Lelièvre, Jacques Morel, Stéphanie Nguyen, Jean‐Philippe Spano, Benjamin Terrier, Anne Thiébaut, Jean‐François Viallard, François Vrtovsnik, Xavier de Lamballerie, Odile Launay,

COVID-19 Clinical Research Studies

Of course, we concentrated not only on COVID-19 but also on other diseases.In total, we helped the population with 31 patient-education videos, 43 social-media appearances and 13 printed patient-information leaflets (Fig. 1i).What does the future hold?It is hard to predict, but it is certainly up to us.We strongly believe that disseminating the model and highlighting the successes it achieves can help.It is an excellent sign that Semmelweis University has already invited us to build the TM cycle in Budapest; moreover, several European and American universities have already expressed interest in introducing the TM cycle model or further developing their existing models.Is this model perfect?Certainly not, but it represents a considerable advance.